Pancreatic Cancer Research

ResearcherFirst Hospital of Jilin UniversityActive in the last 2 years

Yan Jiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6914-7949; OpenAlex author ID A5065649509. Sources: OpenAlex.

Their work

Papers
5 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 3 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 5

  1. Precision medicine advances in pancreatic cancer driven by genomic and molecular alterations. First author DOI 10.4251/wjgo.v17.i11.111264↗
  2. Reassessing the role of lymph node dissection in pancreatic cancer surgery: Balancing oncologic control and immune function preservation. First author DOI 10.4251/wjgo.v17.i11.112248↗
  3. TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer. First author DOI 10.1097/md.0000000000018487↗
  4. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0211291↗
  5. ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer. Co-author DOI 10.2147/ott.s201675↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yahui Liu · 3 shared papers, 2019–2025 · strength 0.67
  2. Yihan Xu · 1 shared paper, 2025 · strength 0.54
  3. Xiang Li · 1 shared paper, 2025 · strength 0.42
  4. Zhuo Fu · 2 shared papers, 2019 · strength 0.24
  5. Songyang Liu · 1 shared paper, 2019 · strength 0.12
  6. Bin Liu · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.